Detalhe da pesquisa
1.
Evaluation of circulating cell-free KRAS mutational status as a molecular monitoring tool in patients with pancreatic cancer.
Pancreatology
; 21(8): 1466-1471, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34511398
2.
Overcoming negative predictions of microRNA expressions to gemcitabine response with FOLFIRINOX in advanced pancreatic cancer patients.
Future Sci OA
; 7(2): FSO644, 2020 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33437513